vs
HACKETT GROUP, INC.（HCKT）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
HACKETT GROUP, INC.的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.0倍（$75.8M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs -4.4%），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs -0.9%）
哈克特集团是源自英国的男童服饰多渠道零售商，主营各类男士及男童服装与配饰，品牌于1983年在英国伦敦创立。截至2019年6月，该品牌在全球共开设160家门店，旗舰店坐落于伦敦萨维尔街14号，目前由黎巴嫩M1集团与美国L资本亚洲共同持有。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
HCKT vs PBYI — 直观对比
营收规模更大
HCKT
是对方的1.0倍
$75.5M
营收增速更快
PBYI
高出32.1%
-4.4%
两年增速更快
PBYI
近两年复合增速
-0.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $75.8M | $75.5M |
| 净利润 | $5.6M | — |
| 毛利率 | 41.7% | 69.3% |
| 营业利润率 | 12.0% | 22.7% |
| 净利率 | 7.4% | — |
| 营收同比 | -4.4% | 27.7% |
| 净利润同比 | 56.9% | — |
| 每股收益（稀释后） | $0.20 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HCKTPBYI
| Q4 25 | $75.8M | $75.5M | ||
| Q3 25 | $73.1M | $54.5M | ||
| Q2 25 | $78.9M | $52.4M | ||
| Q1 25 | $77.9M | $46.0M | ||
| Q4 24 | $79.2M | $59.1M | ||
| Q3 24 | $79.8M | $80.5M | ||
| Q2 24 | $77.7M | $47.1M | ||
| Q1 24 | $77.2M | $43.8M |
净利润HCKTPBYI
| Q4 25 | $5.6M | — | ||
| Q3 25 | $2.5M | $8.8M | ||
| Q2 25 | $1.7M | $5.9M | ||
| Q1 25 | $3.1M | $3.0M | ||
| Q4 24 | $3.6M | — | ||
| Q3 24 | $8.6M | $20.3M | ||
| Q2 24 | $8.7M | $-4.5M | ||
| Q1 24 | $8.7M | $-4.8M |
毛利率HCKTPBYI
| Q4 25 | 41.7% | 69.3% | ||
| Q3 25 | 40.7% | 77.7% | ||
| Q2 25 | 35.4% | 76.5% | ||
| Q1 25 | 35.8% | 77.1% | ||
| Q4 24 | 39.4% | 76.4% | ||
| Q3 24 | 29.2% | 63.9% | ||
| Q2 24 | 27.5% | 77.4% | ||
| Q1 24 | 26.2% | 75.5% |
营业利润率HCKTPBYI
| Q4 25 | 12.0% | 22.7% | ||
| Q3 25 | 7.5% | 17.6% | ||
| Q2 25 | 5.8% | 12.7% | ||
| Q1 25 | 5.7% | 8.7% | ||
| Q4 24 | 9.8% | 22.6% | ||
| Q3 24 | 16.0% | 27.4% | ||
| Q2 24 | 16.1% | -4.6% | ||
| Q1 24 | 14.9% | -5.3% |
净利率HCKTPBYI
| Q4 25 | 7.4% | — | ||
| Q3 25 | 3.5% | 16.2% | ||
| Q2 25 | 2.1% | 11.2% | ||
| Q1 25 | 4.0% | 6.5% | ||
| Q4 24 | 4.5% | — | ||
| Q3 24 | 10.8% | 25.2% | ||
| Q2 24 | 11.3% | -9.6% | ||
| Q1 24 | 11.3% | -11.0% |
每股收益（稀释后）HCKTPBYI
| Q4 25 | $0.20 | $0.26 | ||
| Q3 25 | $0.09 | $0.17 | ||
| Q2 25 | $0.06 | $0.12 | ||
| Q1 25 | $0.11 | $0.06 | ||
| Q4 24 | $0.11 | $0.40 | ||
| Q3 24 | $0.31 | $0.41 | ||
| Q2 24 | $0.31 | $-0.09 | ||
| Q1 24 | $0.32 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $18.2M | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $68.1M | $130.3M |
| 总资产 | $206.4M | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资HCKTPBYI
| Q4 25 | $18.2M | $97.5M | ||
| Q3 25 | $13.9M | $94.4M | ||
| Q2 25 | $10.1M | $96.0M | ||
| Q1 25 | $9.2M | $93.2M | ||
| Q4 24 | $16.4M | $101.0M | ||
| Q3 24 | $10.0M | $96.7M | ||
| Q2 24 | $19.1M | $96.8M | ||
| Q1 24 | $13.0M | $107.2M |
总债务HCKTPBYI
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
股东权益HCKTPBYI
| Q4 25 | $68.1M | $130.3M | ||
| Q3 25 | $101.6M | $115.3M | ||
| Q2 25 | $119.8M | $104.7M | ||
| Q1 25 | $114.4M | $97.1M | ||
| Q4 24 | $115.6M | $92.1M | ||
| Q3 24 | $110.9M | $71.1M | ||
| Q2 24 | $102.2M | $48.5M | ||
| Q1 24 | $93.5M | $51.0M |
总资产HCKTPBYI
| Q4 25 | $206.4M | $216.3M | ||
| Q3 25 | $200.7M | $202.9M | ||
| Q2 25 | $200.5M | $194.9M | ||
| Q1 25 | $191.8M | $196.2M | ||
| Q4 24 | $193.3M | $213.3M | ||
| Q3 24 | $190.8M | $220.7M | ||
| Q2 24 | $187.5M | $205.0M | ||
| Q1 24 | $179.3M | $214.1M |
负债/权益比HCKTPBYI
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $19.1M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | — | $14.4M |
| 自由现金流率自由现金流/营收 | — | 19.1% |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | 3.41× | — |
| 过去12个月自由现金流最近4个季度 | — | $41.7M |
8季度趋势，按日历期对齐
经营现金流HCKTPBYI
| Q4 25 | $19.1M | $14.4M | ||
| Q3 25 | $11.4M | $9.7M | ||
| Q2 25 | $5.6M | $14.1M | ||
| Q1 25 | $4.2M | $3.6M | ||
| Q4 24 | $20.6M | $15.6M | ||
| Q3 24 | $10.6M | $11.0M | ||
| Q2 24 | $13.7M | $1.0M | ||
| Q1 24 | $2.8M | $11.2M |
自由现金流HCKTPBYI
| Q4 25 | — | $14.4M | ||
| Q3 25 | — | $9.7M | ||
| Q2 25 | $3.7M | $14.1M | ||
| Q1 25 | $2.6M | $3.6M | ||
| Q4 24 | $19.6M | $15.6M | ||
| Q3 24 | $9.3M | $11.0M | ||
| Q2 24 | $12.8M | $1.0M | ||
| Q1 24 | $1.8M | — |
自由现金流率HCKTPBYI
| Q4 25 | — | 19.1% | ||
| Q3 25 | — | 17.7% | ||
| Q2 25 | 4.7% | 26.8% | ||
| Q1 25 | 3.4% | 7.7% | ||
| Q4 24 | 24.8% | 26.4% | ||
| Q3 24 | 11.7% | 13.7% | ||
| Q2 24 | 16.5% | 2.1% | ||
| Q1 24 | 2.4% | — |
资本支出强度HCKTPBYI
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | 2.4% | 0.0% | ||
| Q1 25 | 2.0% | 0.1% | ||
| Q4 24 | 1.3% | 0.0% | ||
| Q3 24 | 1.5% | 0.0% | ||
| Q2 24 | 1.1% | 0.0% | ||
| Q1 24 | 1.2% | 0.0% |
现金转化率HCKTPBYI
| Q4 25 | 3.41× | — | ||
| Q3 25 | 4.47× | 1.10× | ||
| Q2 25 | 3.40× | 2.41× | ||
| Q1 25 | 1.33× | 1.21× | ||
| Q4 24 | 5.79× | — | ||
| Q3 24 | 1.23× | 0.54× | ||
| Q2 24 | 1.57× | — | ||
| Q1 24 | 0.32× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HCKT
| Global S And BT | $39.1M | 52% |
| Sap Solutions | $22.4M | 30% |
| Consulting And Software Support And Maintenance | $14.3M | 19% |
PBYI
暂无分部数据
